Cargando…
Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s disease
Triggering receptor expressed on myeloid cells 2 TREM2 was identified as a risk factor for late onset Alzheimer’s disease (AD). Here we compared TREM2 cases with a variant (TREM2(+)) and cases without a TREM2 variant (TREM2(−)), considering pathological burden, inflammatory response and altered cano...
Autores principales: | Toomey, Christina E., Heywood, Wendy, Benson, Bridget C., Packham, Georgia, Mills, Kevin, Lashley, Tammaryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018003/ https://www.ncbi.nlm.nih.gov/pubmed/32267026 http://dx.doi.org/10.1111/bpa.12842 |
Ejemplares similares
-
Microglia‐synapse engulfment via PtdSer‐TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models
por: Rueda‐Carrasco, Javier, et al.
Publicado: (2023) -
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease
por: Heslegrave, Amanda, et al.
Publicado: (2016) -
Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration
por: Woollacott, Ione O. C., et al.
Publicado: (2020) -
The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease
por: Murray, Christina E., et al.
Publicado: (2018) -
Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS
por: Gittings, Lauren M., et al.
Publicado: (2019)